Insider Transactions in Q3 2024 at Arca Biopharma, Inc. (ABIO)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 11
2024
|
Fairmount Funds Management LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
275,000
+30.1%
|
$6,325,000
$23.0 P/Share
|
Aug 16
2024
|
Janus Henderson Group PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,818
+0.14%
|
$11,636
$2.96 P/Share
|
Jul 25
2024
|
Janus Henderson Group PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,227
+1.41%
|
$90,681
$3.05 P/Share
|
Jul 24
2024
|
Janus Henderson Group PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
189,856
+2.87%
|
$569,568
$3.18 P/Share
|
Jul 11
2024
|
Janus Henderson Group PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
94,537
+4.76%
|
$283,611
$3.45 P/Share
|
Jul 10
2024
|
Janus Henderson Group PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
55,463
+1.53%
|
$166,389
$3.46 P/Share
|
Jul 09
2024
|
Janus Henderson Group PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
16,917
+0.96%
|
$50,751
$3.43 P/Share
|
Jul 08
2024
|
Janus Henderson Group PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
47,492
+1.37%
|
$142,476
$3.48 P/Share
|
Jul 05
2024
|
Janus Henderson Group PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
28,326
+0.84%
|
$84,978
$3.42 P/Share
|
Jul 03
2024
|
Janus Henderson Group PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
166,042
+9.15%
|
$498,126
$3.55 P/Share
|